The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 4 rounds in the feed, most often in Healthtech.
thecolumngroup.comRounds from 2020-03-17 to 2026-09-16
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Series E Verified against 5 sources | $92.5M | 2026-09-16 | [ LEAD ] |
Nilo Nilo Therapeutics develops medicines that target neural circuits to restore immune balance in autoimmune and inflammatory disease. | Series A Verified against |
| $101M |
| 2025-10-08 |
| [ LEAD ] |
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Series C Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $66M | 2021-06-16 | [ LEAD ] |
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $45M | 2020-03-17 | [ LEAD ] |